Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Chinese contract manufacturer WuXi Biologics is spending $60 million in Worcester, Mass., to build a plant that will produce biologics and employ as many as 150 people. With a total bioreactor capacity of 4,500 L, the site will primarily employ single-use bioreactors but will also implement a continuous process that WuXi claims to have developed. WuXi has been busily expanding commercial production in recent months with investments totaling hundreds of millions of dollars in new plants in Ireland, Singapore, and China.
This article has been sent to the following recipient: